1. Search Result
Search Result
Results for "

Sleep

" in MedChemExpress (MCE) Product Catalog:

120

Inhibitors & Agonists

4

Screening Libraries

14

Peptides

1

Inhibitory Antibodies

16

Natural
Products

13

Isotope-Labeled Compounds

1

Click Chemistry

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P1501A

    Delta-Sleep Inducing Peptide acetate

    SOD Neurological Disease
    δ-Sleep Inducing Peptide acetate is a neuropeptide, with antioxidant and anxiolytic properties .
    δ-Sleep Inducing Peptide acetate
  • HY-145554

    Others Others
    Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative. Bafrekalant has the potential for the research of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring (extracted from patent WO2018228907A1).
    Bafrekalant
  • HY-W092533

    Tryptophan Hydroxylase Neurological Disease
    6-Fluorotryptophan, a competitive inhibitor of tryptophan hydroxylase, produced a transient disruption of sleep in rats chronically implanted with EEG recording electrodes .
    6-Fluorotryptophan
  • HY-B0478A
    Trazodone
    2 Publications Verification

    AF-1161 free base

    5-HT Receptor Neurological Disease
    Trazodone (AF-1161 free base) is a serotonin receptor antagonist and reuptake inhibitor. Trazodone can be used for the research of major depressive disorder. Trazodone also has potential for sleep disorder research .
    Trazodone
  • HY-19914
    MK-1064
    2 Publications Verification

    Orexin Receptor (OX Receptor) Endocrinology Cancer
    MK-1064 is a selective and orally active OX2R antagonist (Ki: 0.5 nM, IC50: 18 nM). MK-1064 promotes sleep in vivo. MK-1064 can be used in the research of insomnia .
    MK-1064
  • HY-P1501

    Delta-Sleep Inducing Peptide

    SOD Neurological Disease
    δ-Sleep Inducing Peptide is a neuropeptide, with antioxidant and anxiolytic properties.
    δ-Sleep Inducing Peptide
  • HY-101553

    ORF-8063; WE352

    Others Neurological Disease
    Triflubazam is an anti-anxiety agent. Triflubazam can be used for the research of sleep disorder .
    Triflubazam
  • HY-118996A

    Parasite Infection
    Isometamidium chloride is an antiprotozoal agent, that exhibits activity against trypanosome. Isometamidium chloride can be used in research of african sleeping sickness .
    Isometamidium chloride
  • HY-106356

    Cholecystokinin Receptor Others
    GV-150013 is a selective CCK-B receptor antagonist. GV-150013 has sleep aid effect .
    GV-150013
  • HY-14856

    PD 0200390

    GABA Receptor Neurological Disease
    Atagabalin (PD 0200390) is a selective GABA (gamma-aminobutyric acid) receptor agonist with antianxiety and sedative effects. Atagabalin enhances the activity of the GABA receptor by binding to the α2δ subunit of the GABA receptor, thereby increasing the GABA mediated inhibition. This enhancement results in reduced excitability of neurons, helping to reduce anxiety and improve sleep. Atagabalin can be used to study neuropsychiatric disorders, anxiety or sleep disorders .
    Atagabalin
  • HY-105542

    Histamine Receptor Neurological Disease
    Niaprazine is a histamine H1-receptor antagonist. Niaprazine has antihistamine and antiserotonin activities and can be used for sleep disorder research .
    Niaprazine
  • HY-B0478AR

    5-HT Receptor Neurological Disease
    Trazodone (Standard) is the analytical standard of Trazodone. This product is intended for research and analytical applications. Trazodone (AF-1161 free base) is a serotonin receptor antagonist and reuptake inhibitor. Trazodone can be used for the research of major depressive disorder. Trazodone also has potential for sleep disorder research .
    Trazodone (Standard)
  • HY-10232
    THIP
    1 Publications Verification

    Gaboxadol

    GABA Receptor Neurological Disease
    THIP (Gaboxadol) is a selective extrasynaptic GABAA receptors (eGABARs) agonist (with blood-brain barrier permeability), shows an EC50 value of 13 µM for δ-GABAAR. THIP induces strong tense GABAA-mediated currents in layer 2/3 neurons, but shows on effect on miniature IPSCs. THIP can be used in studies of sleep disorders .
    THIP
  • HY-14232

    Calcium Channel Neurological Disease
    TTA-A8 (Compound 13) is a short-acting T-type calcium channel antagonist with oral activity, exhibiting an IC50 value of 31.3 nM in the FLIPR depolarization assay. TTA-A8 possesses favorable pharmacokinetic properties, making it suitable for research on epilepsy and sleep .
    TTA-A8
  • HY-113555

    Orexin Receptor (OX Receptor) Neurological Disease
    DORA 42 is a dual orexin 1 and orexin 2 receptor antagonist with sleep efficacy in rats. DORA 42 is promising for research of insomnia .
    DORA 42
  • HY-101988
    Prostaglandin D2
    1 Publications Verification

    PGD2

    Prostaglandin Receptor Endogenous Metabolite Inflammation/Immunology
    Prostaglandin D2 (PGD2) is one of the major PGs actively produced in the brain of various mammals . Prostaglandin D2 is one of the most potent endogenous sleep promoting substances . PGD2 plays a protective role by suppressing inflammation .
    Prostaglandin D2
  • HY-105542R

    Histamine Receptor Neurological Disease
    Niaprazine (Standard) is the analytical standard of Niaprazine. This product is intended for research and analytical applications. Niaprazine is a histamine H1-receptor antagonist. Niaprazine has antihistamine and antiserotonin activities and can be used for sleep disorder research .
    Niaprazine (Standard)
  • HY-19465

    Others Neurological Disease
    Dasolampanel is a kainate receptor antagonist that helps regulate the excitability of the nervous system by blocking kainate receptors and reducing glutamate-mediated excitatory transmission. Dasolampanel can be used in the study of diseases such as overexcitement and sleep disorders .
    Dasolampanel
  • HY-101988R

    Prostaglandin Receptor Endogenous Metabolite Inflammation/Immunology
    Prostaglandin D2 (Standard) is the analytical standard of Prostaglandin D2. This product is intended for research and analytical applications. Prostaglandin D2 (PGD2) is one of the major PGs actively produced in the brain of various mammals . Prostaglandin D2 is one of the most potent endogenous sleep promoting substances . PGD2 plays a protective role by suppressing inflammation .
    Prostaglandin D2 (Standard)
  • HY-13801
    Fexinidazole
    1 Publications Verification

    HOE 239

    Parasite Infection
    Fexinidazole (HOE 239) is an orally active, potent nitroimidazole antitrypanosomal agent. Fexinidazole shows trypanocidal activity against T. brucei subspecies and strains with IC50s of 0.7-3.3 μM (0.2-0.9 μg/ml). Fexinidazol has the potential for human sleeping sickness (HAT) caused by infection with T. brucei .
    Fexinidazole
  • HY-13801R

    Parasite Infection
    Fexinidazole (Standard) is the analytical standard of Fexinidazole. This product is intended for research and analytical applications. Fexinidazole (HOE 239) is an orally active, potent nitroimidazole antitrypanosomal agent. Fexinidazole shows trypanocidal activity against T. brucei subspecies and strains with IC50s of 0.7-3.3 μM (0.2-0.9 μg/ml). Fexinidazol has the potential for human sleeping sickness (HAT) caused by infection with T. brucei .
    Fexinidazole (Standard)
  • HY-120124

    SUVN-G3031

    Histamine Receptor Neurological Disease
    Samelisant (SUVN-G3031) is a potent and selective histamine H3 receptor (H3R) inverse agonist with good brain penetration and oral bioavailability. Samelisant has a similar binding affinity towards human (hH3R; Ki=8.7 nM) and rat (rH3R;Ki=9.8 nM) H3R indicating no inter-species differences. Samelisant can be used for the research of sleep-related disorders .
    Samelisant
  • HY-P1349A

    Rat orexin B TFA; Orexin B (mouse) (TFA)

    Orexin Receptor (OX Receptor) Neurological Disease Endocrinology
    Orexin B, rat, mouse (Rat orexin B) TFA is an endogenous orexin receptor agonist. Orexin B, rat, mouse TFA binds and activates two closely related orphan G protein-coupled receptors OX1-R and OX2-R. Orexin B, rat, mouse TFA stimulates food intake and energy expenditure and plays a significant role in sleep-wakefulness regulation .
    Orexin B, rat, mouse TFA
  • HY-B1229

    3-Methylbutanamide

    Others Neurological Disease
    Isovaleramide (3-Methylbutanamide) is an orally active anticonvulsant that modulates central nervous system activity. Isovaleramide has anticonvulsant, anxiolytic, sedative, and sleep aid activities. Isovaleramide is promising for research of ethylene glycol (EG) poisoning-induced acute kidney injury and epilepsy .
    Isovaleramide
  • HY-122608

    SUVN-G3031 free base

    Histamine Receptor Neurological Disease
    Samelisant (SUVN-G3031) free base is a potent and selective histamine H3 receptor (H3R) inverse agonist with good brain penetration and oral bioavailability. Samelisant free base has a similar binding affinity towards human (hH3R; Ki=8.7 nM) and rat (rH3R;Ki=9.8 nM) H3R indicating no inter-species differences. Samelisant free base can be used for the research of sleep-related disorders .
    Samelisant free base
  • HY-105285

    Neu-P11

    Melatonin Receptor 5-HT Receptor P2X Receptor TRP Channel Sodium Channel Neurological Disease
    Piromelatine (Neu-P11) is a melatonin MT1/MT2 receptor agonist, serotonin 5-HT1A/5-HT1D agonist, and serotonin 5-HT2B antagonist. Piromelatine (Neu-P11) possesses sleep promoting, analgesic, anti-neurodegenerative, anxiolytic and antidepressant potentials. Piromelatine (Neu-P11) also possesses pain-related P2X3, TRPV1, and Nav1.7 channel-inhibition capacities .
    Piromelatine
  • HY-135222

    5-Methoxy-6-methyl-2-aminoindan hydrochloride

    5-HT Receptor Neurological Disease
    MMAI (5-Methoxy-6-methyl-2-aminoindan) hydrochloride is a selective serotonin releaser that does not produce psychoactive or hallucinogenic effects in the context of drug discrimination in rats. MMAI hydrochloride induces a behavioral syndrome in rats, including hypokinesia with freezing, spinning, Straub tail, flat posture, and reduced sleep time .
    MMAI hydrochloride
  • HY-N3185

    Cholinesterase (ChE) Infection Metabolic Disease Inflammation/Immunology Cancer
    N-Methylcalycinine is a nature product with AChE inhibitory activity. N-Methylcalycinine can be isolated from the roots of Stephania epigaea. N-Methylcalycinine can be used for the research of asthma, cancer, dysentery, fever, hyperglycemia, intestinal complaints, inflammation, sleep disturbances, tuberculosis and so on .
    N-Methylcalycinine
  • HY-N0179
    Ecdysone
    1 Publications Verification

    α-Ecdysone

    Endogenous Metabolite Apoptosis Metabolic Disease
    Ecdysone (α-Ecdysone), a major steroid hormone in insects and herbs, triggers mineralocorticoid receptor (MR) activation and induces cellular apoptosis. Ecdysone plays essential roles in coordinating developmental transitions and homeostatic sleep regulation through its active metabolite 20-hydroxyecdysone (Crustecdysone; 20E; HY-N6979) .
    Ecdysone
  • HY-P5711

    Bacterial Infection
    NEMURI is an antimicrobial peptide with sleep-promoting effect .
    NEMURI
  • HY-111828
    TTA-A2
    1 Publications Verification

    Calcium Channel Neurological Disease
    TTA-A2 is a potent, selective and orally active t-type voltage gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation. TTA-A2 is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels with IC50 values of 89 nM and 92 nM, respectively, at -80 and -100 mV holding potentials. TTA-A2 can be used for the research of a variety of human neurological diseases, including sleep disorders and epilepsy .
    TTA-A2
  • HY-106547

    GABA Receptor Neurological Disease
    Rilmazafone is a benzodiazepine ω ligand and an orally active sleep inducer .
    Rilmazafone
  • HY-N2015

    Others Neurological Disease
    Hastatoside is an iridoid glycoside that is isolated from Verbena officinalis and has a role in promoting sleep .
    Hastatoside
  • HY-U00049

    Others Cardiovascular Disease Neurological Disease
    Mioflazine is an orally active nucleoside transport inhibitor, has the potential for sleep disorders treatment. Mioflazine inhibits nucleoside uptake .
    Mioflazine
  • HY-106917

    Ro 41-3696

    GABA Receptor Neurological Disease
    Lirequinil (Ro 41-3696) is an orally active partial agonist of the benzodiazepine (BDZ) receptor. Lirequinil has the effect of promoting sleep .
    Lirequinil
  • HY-127159

    Drug Metabolite Others
    Laurencin is a cyclic ether, which can be isolated red alga L. glandulifera. Laurencin prolongs the pentobarbitone-induced sleep time through inhibition of pentobarbitone metabolism .
    Laurencin
  • HY-19371

    GABA Receptor Neurological Disease
    Lorediplon is a novel non-benzodiazepine drug acting as a GABAA receptor modulator, differentially active at the alpha1-subunit, associated with promoting sleep.
    Lorediplon
  • HY-124393

    mGluR Neurological Disease
    GRN-529 is a negative allosteric modulator (NAM) for mGluR5. GRN-259 modulates sleep-wake activity, and exhibits anxiolytic efficacy in rats .
    GRN-529
  • HY-130689

    Others Neurological Disease
    Pinoxepin hydrochloride is an antipsychotic drug with sedative and antidepressant activities. Pinoxepin hydrochloride is used to suppress mental disorders such as schizophrenia and depression. Pinoxepin hydrochloride also has the effect of improving sleep quality .
    Pinoxepin hydrochloride
  • HY-116152A

    (S)-Ciprofol; (S)-HSK3486

    GABA Receptor Neurological Disease
    (S)-Cipepofol is the isomer of Cipepofol (HY-116152).Cipepofol (HSK3486) is a sleep-promoting active molecule and a gamma-aminobutyric acid (GABA) receptor enhancer .
    (S)-Cipepofol
  • HY-N2015R

    Others Neurological Disease
    Hastatoside (Standard) is the analytical standard of Hastatoside. This product is intended for research and analytical applications. Hastatoside is an iridoid glycoside that is isolated from Verbena officinalis and has a role in promoting sleep .
    Hastatoside (Standard)
  • HY-10896
    JNJ-10397049
    1 Publications Verification

    Orexin Receptor (OX Receptor) Neurological Disease
    JNJ-10397049 is a potent and selective orexin 2 receptor (OX2R) antagonist, with a pKi of 8.3. JNJ-10397049 is 600-fold selective for the OX2R over the OX1R .
    JNJ-10397049
  • HY-136922

    Orexin Receptor (OX Receptor) Neurological Disease
    Orexin receptor antagonist 2 (compound 30) is a potent orexin receptor antagonist with pKis of 7.69 and 9.78. Orexin receptor antagonist 2 has the potential for the research of insomnia .
    Orexin receptor antagonist 2
  • HY-101260

    Orexin Receptor (OX Receptor) Neurological Disease
    DORA-22 is an orally active dual orexinergic receptor antagonist, and improves the sleep disruption and memory impairment. DORA-22 can be used for study of insomnia .
    DORA-22
  • HY-129250

    Histamine Receptor Neurological Disease
    AZD5213 is a selective and competitive human H3 receptor antagonist with a pKi value of 9.3 for hH3R. AZD5213 can be used for the research of sleep and cognitive regulation .
    AZD5213
  • HY-B2169

    Others Neurological Disease
    Melperone, a butyrophenone, is an antipsychotic agent used for sleep induction which is frequently prescribed in psychiatric setting . Melperone has been used for a variety of indications, including the treatment of schizophrenia, but also for agitation in the elderly .
    Melperone
  • HY-116046

    Melatonin Receptor Others
    GR 196429 is a melatonin receptor agonist with some selectivity for the MT1 subtype. GR 196429 produces both sleep-promoting effects and alterations of circadian rhythm, as well as stimulating melatonin release in mice .
    GR 196429
  • HY-116236

    LY2607540

    Others Others
    THIIC (LY2607540) is a compound with anxiolytic and antidepressant potential. It is a positive allosteric modulator of mGlu? receptors, exhibits anxiolytic and antidepressant-like activities in multiple animal models, and can also affect sleep and neurochemical changes.
    THIIC
  • HY-114542

    Others Others
    LY 201409 is a compound with anticonvulsant activity that can antagonize maximal electroconvulsive-induced epileptic seizures, has mixed effects on epileptic seizures induced by a variety of chemical convulsants, and can also affect the behavior and sleep of mice.
    LY 201409
  • HY-N7944

    Others Cancer
    Eucommiol is a natural product that can be isolated from the roasted leaves of E. ulmoides. Eucommiol inhibits growth of Molt 4B cells. Eucommiol reduces spontaneous activity and increases the sleep ratio in mice .
    Eucommiol

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: